Drugs / CHIR-258
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 1 | NCT01270906 | Dec 2003 → Oct 2006 | cancer | Novartis Pharmaceuticals | Terminated | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | CHIR-258 | ClinicalTrials.gov intervention name — accepted as the source's own label NCT01270906 ↗ |
| Known as | TKI258 | “CHIR-258 (TKI258)” NCT01270906 ↗ |